Literature DB >> 18249083

Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.

Christian Bories1, Sandrine Cojean, Françoise Huteau, Philippe M Loiseau.   

Abstract

A Leishmania donovani promastigote line resistant to 160microM sitamaquine, named SITA-160R, was selected in vitro by continuous stepwise drug pressure. SITA-160R line was able to infect murine peritoneal macrophages in vitro in the same manner as the wild-type line (WT) but was less infective for Balb/c mice than its parent WT clone. This line was about five and three times more resistant to sitamaquine than the WT line on promastigote and intramacrophage amastigote forms, respectively. No cross-resistance with other antileishmanial agents was observed and this resistance was stable when parasites were subcultured in drug-free medium for a long time or after in vivo passage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249083     DOI: 10.1016/j.biopha.2007.12.006

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Investigational drugs for visceral leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Investig Drugs       Date:  2014-11-20       Impact factor: 6.206

2.  Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species.

Authors:  Daniel B Liarte; Silvane M F Murta
Journal:  Parasitol Res       Date:  2010-04-07       Impact factor: 2.289

3.  Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major.

Authors:  José Ignacio Manzano; Luis Carvalho; José M Pérez-Victoria; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

4.  Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquine.

Authors:  Arpita Kulshrestha; Ruchi Singh; Dhiraj Kumar; Narender Singh Negi; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

Review 5.  Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance.

Authors:  P M Loiseau; S Cojean; J Schrével
Journal:  Parasite       Date:  2011-05       Impact factor: 3.000

Review 6.  The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates.

Authors:  Philippe M Loiseau; Kaluvu Balaraman; Gillian Barratt; Sébastien Pomel; Rémy Durand; Frédéric Frézard; Bruno Figadère
Journal:  Molecules       Date:  2022-04-02       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.